Wednesday, April 20, 2016

BRIEF-Baxter receives marketing authorization in UK, Denmark for NUMETA G13E

* Baxter receives marketing authorization in the united

kingdom and denmark for numeta g13e ready-to-use iv nutrition

for preterm newborns

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)